Platelet inhibitory effect of nitric oxide in the human coronary circulation: impact of endothelial dysfunction

Furchgott, 1980, The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature, 288, 373, 10.1038/288373a0 Vanhoutte, 1988, The endothelium. Modulator of vascular smooth muscle tone, N Engl J Med, 319, 512, 10.1056/NEJM198808253190809 Palmer, 1987, Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature, 327, 524, 10.1038/327524a0 Feletou, 1988, Endothelium-dependent hyperpolarization of canine coronary smooth muscle, Br J Pharmacol, 93, 515, 10.1111/j.1476-5381.1988.tb10306.x De Mey, 1982, Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery, J Pharmacol Exp Ther, 222, 166 Palmer, 1987, Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature, 327, 524, 10.1038/327524a0 Myers, 1990, Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide, Nature, 345, 161, 10.1038/345161a0 Mellion, 1981, Evidence for the inhibitory role of guanosine 3′5′-monophosphate in ADP-induced platelet aggregation in the presence of nitric oxide and related vasodilators, Blood, 57, 946, 10.1182/blood.V57.5.946.946 Azuma, 1986, Endothelium-dependent inhibition of platelet aggregation, Br J Pharmacol, 88, 411, 10.1111/j.1476-5381.1986.tb10218.x Furlong, 1987, Endothelium-derived relaxing factor inhibits in vitro platelet aggregation, Br J Pharmacol, 90, 687, 10.1111/j.1476-5381.1987.tb11221.x Radomski, 1990, An L-arginine/nitric oxide pathway present in human platelets regulates aggregation, PNAS, 87, 5193, 10.1073/pnas.87.13.5193 Pohl, 1989, EDRF increases cyclic GMP in platelets during passage through the coronary vascular bed, Circ Res, 65, 1798, 10.1161/01.RES.65.6.1798 Bhardwaj, 1988, Endothelium-derived relaxing factor inhibits platelet aggregation in human whole blood in vitro and in the rat in vivo, Eur J Pharmacol, 157, 83, 10.1016/0014-2999(88)90474-8 Hogan, 1988, In vivo EDRF activity influences platelet function, Br J Pharmacol, 94, 1020, 10.1111/j.1476-5381.1988.tb11616.x Radomski, 1987, The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium, Biochem Biophys Res Commun, 148, 1482, 10.1016/S0006-291X(87)80299-1 Groves, 1993, SIN-1 reduces platelet thrombus formation in a porcine model of balloon angioplasty, Circulation, 87, 590, 10.1161/01.CIR.87.2.590 Yao, 1992, Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries, Circulation, 86, 1302, 10.1161/01.CIR.86.4.1302 Quyyumi, 1995, Nitric oxide activity in the human coronary circulation, J Clin Invest, 95, 1747, 10.1172/JCI117852 Quyyumi, 1997, Impaired release of nitric oxide from atherosclerotic human coronary vasculature, J Am Coll Cardiol, 29, 308, 10.1016/S0735-1097(96)00472-X Quyyumi, 1997, Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia, Circulation, 95, 104, 10.1161/01.CIR.95.1.104 Diodati, 1992, Platelet hyperaggregability across the coronary bed in response to rapid atrial pacing in patients with stable coronary artery disease, Circulation, 56, 1186, 10.1161/01.CIR.86.4.1186 Doucette, 1992, Validation of a doppler guide wire for intravascular measurement of coronary artery flow velocity, Circulation, 85, 1899, 10.1161/01.CIR.85.5.1899 Glantz, 1990, Repeated measures, 381 SAS Institute Inc. SAS technical report p-229 SAS/STST Software: Changes and Enhancements Release 6.07. Cary, NC: SAS Institute, 1992. Rapoport, 1983, Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation, Nature, 306, 174, 10.1038/306174a0 Radomski, 1987, The anti-aggregating properties of vascular endothelium, Br J Pharmacol, 92, 639, 10.1111/j.1476-5381.1987.tb11367.x MacIntyre, 1985, Regulation of platelet cytosolic free calcium by cyclic nucleotides and protein kinase C, FEBS Lett, 188, 383, 10.1016/0014-5793(85)80407-5 Nakashima, 1986, Inhibitory role of cyclic GMP on secretion, polyphosphoinositide hydrolysis and calcium mobilization in thrombin-stimulated human platelets, Biochem Biophys Res Commun, 135, 10099, 10.1016/0006-291X(86)91041-7 Vallance, 1992, The effect of endothelium-derived nitric oxide on ex vivo whole blood platelet aggregation in man, Eur J Clin Pharmacol, 42, 37, 10.1007/BF00314917 Martin, 1983, Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by haemoglobin and by methylene blue in the rabbit aorta, J Pharmacol Exp Ther, 232, 708 Edwards, 1986, Haptoglobin-haemoglobin complex in human plasma inhibits endothelium-dependent relaxation, Cardiovasc Res, 20, 549, 10.1093/cvr/20.8.549 Mugge, 1993, Impaired coronary dilator responses to substance P and impaired flow-dependent dilator responses in heart transplant patients with graft vasculopathy, J Am Coll Cardiol, 21, 163, 10.1016/0735-1097(93)90732-G Diodati, 1998, Effect of atherosclerosis on endothelium-dependent inhibition of platelet activation in humans, Circulation, 98, 17, 10.1161/01.CIR.98.1.17 Hawkins, 1988, Activation of guanylate cyclase and inhibition of platelet aggregation by endothelium-derived relaxing factor released from cultured cells, Biochimica Biophysica Acta, 969, 289, 10.1016/0167-4889(88)90064-X Mendelsohn, 1990, Inhibition of fibrinogen binding to human platelets by s-nitroso-N-acetylcysteine, J Biol Chem, 265, 19028, 10.1016/S0021-9258(17)30619-1 Jia, 1996, S-nitrosohaemoglobin, Nature, 380, 221, 10.1038/380221a0 Pawloski, 1998, Cell-free and erythrocytic s-nitrosohemoglobin inhibits human platelet aggregation, Circulation, 97, 263, 10.1161/01.CIR.97.3.263 Ludmer, 1986, Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries, N Engl J Med, 315, 1046, 10.1056/NEJM198610233151702 Vita, 1990, Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease, Circulation, 81, 491, 10.1161/01.CIR.81.2.491 Egashira, 1993, Impaired coronary blood flow response to acetylcholine in patients with coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions, J Clin Invest, 91, 29, 10.1172/JCI116183 Diodati, 1995, Inhibitory effect of nitroglycerin and sodium nitroprusside on platelet activation across the coronary circulation in stable angina pectoris, Am J Cardiol, 75, 443, 10.1016/S0002-9149(99)80578-5 Diodati, 1993, Complexes of nitric oxide with nucleophiles as agents for the controlled biologic release of nitric oxide, Thromb Haem, 70, 654, 10.1055/s-0038-1649644 Rovin, 1993, Sodium nitroprusside, an endothelium-derived relaxing factor cogener, increases platelet cyclic GMP levels and inhibits epinephrine-exacerbated in vivo platelet thrombus formation in stenosed canine coronary arteries, J Cardiovasc Pharmacol, 22, 626, 10.1097/00005344-199310000-00017 Stamler, 1991, The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders, J Am Coll Cardiol, 18, 1529, 10.1016/0735-1097(91)90686-4 Saxon, 1976, Platelet inhibition by sodium nitroprusside, a smooth muscle inhibitor, Blood, 47, 957, 10.1182/blood.V47.6.957.957 Böhme, 1978, Effects of sodium nitroprusside and other smooth muscle cell relaxants on cyclic GMP formation in smooth muscle and platelets, Adv Cyclic Nucleotide Res, 9, 131 Levin, 1982, The interaction of sodium nitroprusside with human endothelial cells and platelets, Circulation, 66, 1299, 10.1161/01.CIR.66.6.1299 Zakhary, 1996, Heme oxygenase 2, Proc Natl Acad Sci USA, 93, 795, 10.1073/pnas.93.2.795 Wagner, 1997, Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells, J Clin Invest, 100, 589, 10.1172/JCI119569 Sharp, 1990, The association of platelet and red cell count with impedance changes in whole blood and light-scattering changes in platelet rich plasma, Thromb Haemost, 64, 211, 10.1055/s-0038-1647287 Thaulow, 1991, Blood platelet count and function are related to total and cardiovascular death in apparently healthy men, Circulation, 84, 613, 10.1161/01.CIR.84.2.613 Ross, 1981, Atherosclerosis, Arteriosclerosis, 1, 293, 10.1161/01.ATV.1.5.293